Inactive Instrument

EPS Holdings, Inc. Stock price

Equities

4282

JP3130770005

Biotechnology & Medical Research

Dynamic Chart
GNI Group Ltd. forms joint venture with EPS in Japan focusing on medical device business CI
MedPeer,Inc. completed the acquisition of Ep-Force Co.,Ltd. from EPS Holdings, Inc. and others. CI
MedPeer,Inc. announced that it has received ¥306.9 million in funding from EPS Holdings, Inc. CI
MedPeer,Inc. entered into an agreement to acquire Ep-Force Co.,Ltd. from EPS Holdings, Inc. and others for Ñ5000 million. CI
MedPeer,Inc. announced that it expects to receive Ñ306.9 million in funding from EPS Holdings, Inc. CI
Suzuken Co., Ltd. completed the acquisition of 49% stake in EP-PharmaLine Co., Ltd. from EPS Holdings, Inc. CI
Suzuken Co., Ltd. agreed to acquire 49% stake in EP-PharmaLine Co., Ltd. from EPS Holdings, Inc. CI
EPS Holdings, Inc.(TSE:4282) dropped from S&P Global BMI Index CI
Speed Apparel : EPS Creative Setting Up $2 Million Startup Fund MT
Y&G Limited completed the acquisition of additional 65.7% stake in EPS Holdings, Inc. from Suzuken Co., Ltd., Medical System Network Co., Ltd. and others for ¥ 53.4 billion. CI
Speed Apparel : Restores Public Float to 25% MT
Speed Apparel : EPS Closes Mandatory Takeover Bid for Speed Apparel MT
Y&G Limited made an offer to acquire remaining 78% stake in EPS Holdings, Inc. from Suzuken Co., Ltd., Medical System Network Co., Ltd. and others for ¥62.2 billion. CI
Speed Apparel : Japan's EPS Buys Controlling Stake in Hong Kong's Speed Apparel Under Smart Wear Push MT
EPS Holdings, Inc. made a mandatory offer to acquire remaining 25% stake in Speed Apparel Holding Limited for approximately HKD 120 million. CI
More news
Managers TitleAgeSince
Chief Executive Officer 61 91-04-30
President - -
Director/Board Member - -
Members of the board TitleAgeSince
Chief Executive Officer 61 91-04-30
Director/Board Member 77 11-11-30
Director/Board Member 67 11-03-31
More insiders
EPS Holdings, Inc., formerly EPS Corporation, mainly offers medical-related services. Contract Research Organization (CRO) segment provides clinical trials operating and management-related services. Site Management Organization (SMO) segment offers clinical research coordinators (CRCs) to medical institutions. Contract Research Organization (CSO) segment provides drug information and awareness advertisement reception service to medical and pharmaceutical, healthcare industries. Pharmaceutical and Medical Information Technology-related segment is engaged in the development and support service of systems used for clinical trials.
More about the company
  1. Stock
  2. Equities
  3. Stock EPS Holdings, Inc. - Japan Exchange